|
In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier
|
journal
|
January 2019 |
|
Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948
|
journal
|
October 2019 |
|
Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease
|
journal
|
October 2018 |
|
Quantification of Tau Load Using [18F]AV1451 PET
|
journal
|
April 2017 |
|
Extracellular Vesicle Biology in Alzheimer’s Disease and Related Tauopathy
|
journal
|
November 2017 |
|
A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley?
|
journal
|
July 2017 |
|
The development and validation of tau PET tracers: current status and future directions
|
journal
|
July 2018 |
|
Continuous measurement of object location memory is sensitive to effects of age and mild cognitive impairment and related to medial temporal lobe volume
|
journal
|
November 2017 |
|
Elevated medial temporal lobe and pervasive brain tau‐PET signal in normal participants
|
journal
|
January 2018 |
|
Topographic staging of tau positron emission tomography images
|
journal
|
January 2018 |
|
Tau positron emission tomography imaging in tauopathies: The added hurdle of off‐target binding
|
journal
|
January 2018 |
|
Cross‐sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
|
journal
|
January 2018 |
|
Staging of amyloid β, t‐tau, regional atrophy rates, and cognitive change in a nondemented cohort: Results of serial mediation analyses
|
journal
|
January 2018 |
|
White matter alterations in early‐stage Alzheimer's disease: A tract‐specific study
|
journal
|
December 2019 |
|
A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease
|
journal
|
August 2017 |
|
PET staging of amyloidosis using striatum
|
journal
|
May 2018 |
|
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
|
journal
|
January 2018 |
|
Metabolic brain networks in aging and preclinical Alzheimer's disease
|
journal
|
January 2018 |
|
Positron emission tomography of tau in Iraq and Afghanistan Veterans with blast neurotrauma
|
journal
|
January 2019 |
|
Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain
|
journal
|
January 2019 |
|
Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease
|
journal
|
January 2020 |
|
Alzheimer's drug-development pipeline: 2016
|
journal
|
August 2016 |
|
Imaging the ageing brain: identifying early disease or opening Pandora's box?
|
journal
|
June 2017 |
|
Tau PET imaging in neurodegenerative tauopathies—still a challenge
|
journal
|
January 2019 |
|
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
|
journal
|
April 2019 |
|
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
|
journal
|
January 2020 |
|
Imaging tau pathology in Parkinsonisms
|
journal
|
June 2017 |
|
Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy
|
journal
|
June 2019 |
|
Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals
|
journal
|
February 2018 |
|
The Amazon rain forest plant Uncaria tomentosa (cat’s claw) and its specific proanthocyanidin constituents are potent inhibitors and reducers of both brain plaques and tangles
|
journal
|
February 2019 |
|
18F-Flortaucipir in TDP-43 associated frontotemporal dementia
|
journal
|
April 2019 |
|
Dissociable age and memory relationships with hippocampal subfield volumes in vivo:Data from the Irish Longitudinal Study on Ageing (TILDA)
|
journal
|
July 2019 |
|
Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer’s disease
|
journal
|
October 2019 |
|
Locus coeruleus integrity in old age is selectively related to memories linked with salient negative events
|
journal
|
February 2018 |
|
18 F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
|
journal
|
June 2016 |
|
Longitudinal tau PET in ageing and Alzheimer’s disease
|
journal
|
March 2018 |
|
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia
|
journal
|
April 2019 |
|
The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
|
journal
|
September 2019 |
|
Is tau in the absence of amyloid on the Alzheimer’s continuum?: A study of discordant PET positivity
|
journal
|
December 2019 |
|
Relationships Between Tau and Glucose Metabolism Reflect Alzheimer’s Disease Pathology in Cognitively Normal Older Adults
|
journal
|
April 2018 |
|
The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases
|
journal
|
November 2017 |
|
SC-GAN: 3D self-attention conditional GAN with spectral normalization for multi-modal neuroimaging synthesis
|
journal
|
June 2020 |
|
Aβ-Positivity Predicts Cognitive Decline but Cognition Also Predicts Progression to Aβ-Positivity
|
posted_content
|
September 2019 |
|
Linking molecular pathways and large-scale computational modeling to assess candidate disease mechanisms and pharmacodynamics in Alzheimer’s disease
|
journal
|
April 2019 |
|
Tau pathology in cognitively normal older adults
|
posted_content
|
July 2019 |
|
A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease
|
journal
|
August 2016 |
|
Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer’s disease
|
journal
|
March 2019 |
|
Brain network alterations in individuals with and without mild cognitive impairment: parallel independent component analysis of AV1451 and AV45 positron emission tomography
|
journal
|
June 2019 |
|
Tau PET imaging: present and future directions
|
journal
|
February 2017 |
|
Neuroimaging Biomarkers for Alzheimer’s Disease
|
journal
|
June 2019 |
|
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
|
journal
|
October 2018 |
|
18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
|
journal
|
January 2019 |
|
Tau and atrophy: domain-specific relationships with cognition
|
journal
|
July 2019 |
|
Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
|
journal
|
December 2018 |
|
Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue
|
journal
|
March 2019 |
|
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
|
journal
|
July 2016 |
|
Elevated 18 F-AV-1451 PET tracer uptake detected in incidental imaging findings
|
journal
|
February 2017 |
|
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
|
journal
|
January 2019 |
|
Neuroimaging in aging: brain maintenance
|
journal
|
January 2017 |
|
Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC
|
journal
|
January 2018 |
|
Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer’s disease differ according to disease severity and amyloid positivity
|
journal
|
December 2019 |
|
Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer’s Disease
|
journal
|
January 2018 |
|
Tau and β-Amyloid Burden Predict Actigraphy-Measured and Self-Reported Impairment and Misperception of Human Sleep
|
journal
|
July 2021 |
|
Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity
|
journal
|
November 2018 |
|
Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals
|
journal
|
March 2017 |
|
[18F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia
|
journalarticle
|
January 2017 |
|
Tau Burden and the Functional Connectome in Alzheimer's Disease and Progressive Supranuclear Palsy
|
text
|
January 2017 |
|
MAPT rs242557 variant is associated with hippocampus tau uptake on 18F-AV-1451 PET in non-demented elders
|
journal
|
January 2019 |
|
Genomic deletion of TLR2 induces aggravated white matter damage and deteriorated neurobehavioral functions in mouse models of Alzheimer’s disease
|
journal
|
September 2019 |
|
PET/CT of Dementia
|
journal
|
August 2018 |
|
Modeling Prion-Like Processing of Tau Protein in Alzheimer’s Disease for Pharmaceutical Development
|
journal
|
March 2018 |
|
Amyloid Associated Intermittent Network Disruptions in Cognitively Intact Older Subjects: Structural Connectivity Matters
|
journal
|
December 2017 |
|
Precision Aging: Applying Precision Medicine to the Field of Cognitive Aging
|
journal
|
June 2019 |
|
Topographical Heterogeneity of Alzheimer’s Disease Based on MR Imaging, Tau PET, and Amyloid PET
|
journal
|
August 2019 |
|
The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
|
journal
|
December 2019 |
|
Quantitative 18F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients
|
journal
|
May 2019 |
|
Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks
|
journal
|
March 2017 |
|
Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease
|
journal
|
May 2017 |
|
Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography
|
journal
|
June 2019 |
|
MRI-Driven PET Image Optimization for Neurological Applications
|
journal
|
July 2019 |
|
Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology
|
journal
|
March 2017 |
|
Static and Dynamic Cognitive Reserve Proxy Measures: Interactions with Alzheimer’s Disease Neuropathology and Cognition
|
journal
|
January 2017 |
|
Neural correlates of episodic memory in the Memento cohort
|
text
|
January 2018 |
|
Spatial Registration Evaluation of [18F]-MK6240 PET
|
preprint
|
January 2020 |
|
Additional file 1 of Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study
|
dataset
|
January 2020 |
|
Additional file 1 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
|
image
|
January 2022 |
|
Additional file 2 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
|
image
|
January 2022 |
|
Additional file 3 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
|
image
|
January 2022 |
|
Additional file 4 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
|
image
|
January 2022 |
|
Additional file 5 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
|
image
|
January 2022 |
|
Additional file 6 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
|
image
|
January 2022 |
|
Additional file 7 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
|
image
|
January 2022 |
|
Additional file 8 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
|
dataset
|
January 2022 |
|
Additional file 9 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
|
dataset
|
January 2022 |
|
Alteration of perivascular spaces in early cognitive decline: Neuroimaging / Optimal neuroimaging measures for early detection
|
journal
|
December 2020 |
|
[F-18]AV-1451 positron emission tomography retention in choroid plexus: More than “off-target” binding
|
journal
|
July 2016 |
|
AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies: Tau and Amyloid PET in DLB
|
journal
|
December 2016 |
|
Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies: Tau Imaging: Pathological Correlations
|
journal
|
January 2017 |
|
Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline: Tau, Amyloid, FDG, and Memory in Normal Aging
|
journal
|
April 2017 |
|
Dendritic spines provide cognitive resilience against Alzheimer's disease: Synaptic Resilience in AD
|
journal
|
October 2017 |
|
18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study : Flortaucipir Tau PET in PSP
|
journal
|
October 2017 |
|
Longitudinal tau accumulation and atrophy in aging and alzheimer disease: Tau-PET and Atrophy
|
journal
|
January 2019 |
|
Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome
|
journal
|
December 2018 |
|
Gray matter asymmetries in aging and neurodegeneration: A review and meta-analysis: VBM-ALE Analysis of GM Asymmetries
|
journal
|
August 2017 |
|
Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease
|
journal
|
October 2018 |
|
Effective connectivity in the default mode network is distinctively disrupted in Alzheimer's disease-A simultaneous resting-state FDG-PET/fMRI study
|
journal
|
January 2019 |
|
[ 18 F]AV-1451 tau positron emission tomography in progressive supranuclear palsy : Tau-pet in Progressive Supranuclear Palsy
|
journal
|
October 2016 |
|
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?: Neuroimaging Biomarkers for Diagnosis in PSP
|
journal
|
May 2017 |
|
[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease
|
journal
|
June 2019 |
|
Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients
|
journal
|
August 2019 |
|
The A/T/N model applied through imaging biomarkers in a memory clinic
|
journal
|
December 2019 |
|
Direct attenuation correction of brain PET images using only emission data via a deep convolutional encoder-decoder (Deep-DAC)
|
journal
|
June 2019 |
|
[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging
|
journal
|
June 2017 |
|
In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease
|
journal
|
May 2019 |
|
[18F]-AV-1451 tau PET imaging in Alzheimer’s disease and suspected non-AD tauopathies using a late acquisition time window
|
journal
|
September 2019 |
|
MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding
|
journal
|
November 2017 |
|
PET imaging of tau protein targets: a methodology perspective
|
journal
|
March 2018 |
|
A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer’s Disease
|
journal
|
August 2016 |
|
A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [18F]THK5351 and [11C]PIB
|
journal
|
June 2017 |
|
Brain Theranostics and Radiotheranostics: Exosomes and Graphenes In Vivo as Novel Brain Theranostics
|
journal
|
November 2018 |
|
Biomarkers for the Early Detection and Progression of Alzheimer’s Disease
|
journal
|
October 2016 |
|
Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [ 11 C]PBB3‐PET study
|
journal
|
December 2016 |
|
Tau pathology in cognitively normal older adults
|
journal
|
December 2019 |
|
Tau: From research to clinical development
|
journal
|
May 2016 |
|
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
|
journal
|
March 2017 |
|
The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement
|
journal
|
December 2016 |
|
Tau and amyloid β proteins distinctively associate to functional network changes in the aging brain
|
journal
|
March 2017 |
|
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
|
journal
|
April 2018 |
|
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable
|
journal
|
April 2018 |
|
Molecular imaging in dementia: Past, present, and future
|
journal
|
July 2018 |
|
Predicting diagnosis and cognition with 18 F-AV-1451 tau PET and structural MRI in Alzheimer's disease
|
journal
|
January 2019 |
|
Aβ-Positivity Predicts Cognitive Decline but Cognition also Predicts Progression to Aβ-Positivity
|
journal
|
July 2019 |
|
Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia
|
journal
|
May 2017 |
|
The road to restoring neural circuits for the treatment of Alzheimer's disease
|
journal
|
November 2016 |
|
Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
|
journal
|
December 2017 |
|
Tau-based therapies in neurodegeneration: opportunities and challenges
|
journal
|
October 2017 |
|
A clinicopathological approach to the diagnosis of dementia
|
journal
|
July 2017 |
|
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
|
journal
|
February 2018 |
|
Regional tau pathology and loneliness in cognitively normal older adults
|
journal
|
December 2018 |
|
Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms
|
journal
|
May 2019 |
|
Tau deposition is associated with functional isolation of the hippocampus in aging
|
journal
|
October 2019 |
|
Imaging the evolution and pathophysiology of Alzheimer disease
|
journal
|
September 2018 |
|
Neurogenetic contributions to amyloid beta and tau spreading in the human cortex
|
journal
|
October 2018 |
|
Following the pathway to Alzheimer’s disease
|
journal
|
February 2018 |
|
Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo
|
journal
|
December 2018 |
|
Simultaneous Covariance Inference for Multimodal Integrative Analysis
|
journal
|
June 2019 |
|
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
|
journal
|
October 2017 |
|
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
|
journal
|
January 2017 |
|
18 F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy
|
journal
|
January 2017 |
|
Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals
|
journal
|
March 2017 |
|
Selective impairment of hippocampus and posterior hub areas in Alzheimer’s disease: an MEG-based multiplex network study
|
journal
|
March 2017 |
|
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer’s disease
|
journal
|
July 2017 |
|
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease
|
journal
|
October 2017 |
|
Widespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia
|
journal
|
December 2017 |
|
Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy
|
journal
|
January 2018 |
|
Networks of tau distribution in Alzheimer’s disease
|
journal
|
January 2018 |
|
Plasma tau/amyloid-β1–42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer’s disease
|
journal
|
January 2019 |
|
Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers
|
journal
|
February 2019 |
|
Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects
|
journal
|
February 2019 |
|
Functional connectivity associated with tau levels in ageing, Alzheimer’s, and small vessel disease
|
journal
|
February 2019 |
|
Plasma tau/amyloid-β1–42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer’s disease [Correction]
|
journal
|
February 2019 |
|
Alzheimer’s pathology targets distinct memory networks in the ageing brain
|
journal
|
June 2019 |
|
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
|
journal
|
December 2019 |
|
Comparison of Amyloid β and Tau Spread Models in Alzheimer’s Disease
|
journal
|
December 2018 |
|
Tau Positron Emission Tomography Binding Is Not Elevated in HIV-Infected Individuals
|
journal
|
December 2018 |
|
Sleep–wake regulation and the hallmarks of the pathogenesis of Alzheimer’s disease
|
journal
|
January 2019 |
|
Alteration of perivascular spaces in early cognitive decline
|
posted_content
|
January 2020 |
|
Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Workflow for Research and Clinical Brain PET Applications
|
posted_content
|
April 2019 |
|
Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease
|
journal
|
March 2017 |
|
Review: Neurodegenerative processes in temporal lobe epilepsy with hippocampal sclerosis: Clinical, pathological and neuroimaging evidence
|
journal
|
February 2018 |
|
Staging of tau distribution by positron emission tomography may be useful in clinical staging of Alzheimer disease
|
journal
|
January 2020 |
|
[ 18 F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia
|
journal
|
September 2017 |
|
Flortaucipir tau PET imaging in semantic variant primary progressive aphasia
|
journal
|
October 2017 |
|
Neuronal Cell Death
|
journal
|
April 2018 |
|
The Influence of Dopamine on Cognitive Flexibility Is Mediated by Functional Connectivity in Young but Not Older Adults
|
journal
|
September 2018 |
|
Regional times to equilibria and their impact on semi-quantification of [ 18 F]AV-1451 uptake
|
journal
|
August 2018 |
|
Parametric methods for [ 18 F]flortaucipir PET
|
journal
|
December 2018 |
|
The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease
|
journal
|
September 2018 |
|
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
|
journal
|
July 2019 |
|
A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus
|
journal
|
August 2018 |
|
Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study
|
journal
|
June 2020 |
|
Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias
|
journal
|
May 2018 |
|
[18F]-AV-1451 binding profile in chronic traumatic encephalopathy: a postmortem case series
|
journal
|
October 2019 |
|
Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis
|
journal
|
August 2014 |
|
Molecular biomarkers of Alzheimer's disease: progress and prospects
|
journal
|
May 2018 |
|
The emerging role of PET imaging in dementia
|
journal
|
January 2017 |
|
18 F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
|
journal
|
July 2017 |
|
[18F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia
|
text
|
January 2017 |
|
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
|
text
|
January 2017 |
|
[18F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia
|
journalarticle
|
January 2017 |
|
Neuronal Cell Death.
|
journalarticle
|
January 2018 |
|
A walk through tau therapeutic strategies.
|
text
|
January 2019 |
|
Amyloid-Negative Dementia in the Elderly is Associated with High Accumulation of Tau in the Temporal Lobes
|
journal
|
March 2019 |
|
Plasma Neurofilament Light and Alzheimer’s Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)
|
journal
|
July 2019 |
|
The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer’s Disease
|
journal
|
June 2018 |
|
Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer’s Disease
|
journal
|
May 2019 |
|
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
|
journal
|
January 2018 |
|
Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
|
journal
|
April 2018 |
|
Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species
|
journal
|
June 2019 |
|
A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer’s Disease
|
journal
|
August 2018 |
|
Complexity Changes in Brain Activity in Healthy Ageing: A Permutation Lempel-Ziv Complexity Study of Magnetoencephalograms
|
journal
|
July 2018 |
|
Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
|
journal
|
November 2018 |
|
Simultaneous Covariance Inference for Multimodal Integrative Analysis
|
text
|
January 2019 |
|
Simultaneous Covariance Inference for Multimodal Integrative Analysis
|
text
|
January 2020 |
|
Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models
|
journal
|
March 2019 |
|
Cortical tau deposition follows patterns of entorhinal functional connectivity in aging
|
journal
|
September 2019 |
|
Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity
|
journal
|
December 2019 |
|
Gray matter asymmetries in aging and neurodegeneration: A review and meta-analysis.
|
text
|
January 2017 |